SOLV

시간 외 거래: 73.39

Solventum Corp (SOLV)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Solventum Corp Stock (SOLV) Company Profile

Solventum Corp

Healthcare (1163)

651-733-1110

C/O 3M COMPANY, ST. PAUL

최신 SEC 제출 서류

SOLV's Discussions on Twitter

SOLV을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
SOLV Solventum Corp	73.39	12.56B	8.31B	379.00M	385.00M	2.16
ISRG Intuitive Surgical Inc	470.08	169.94B	9.15B	2.61B	1.99B	7.17
BDX Becton Dickinson Co	193.50	49.41B	21.39B	1.59B	2.55B	5.56
RMD Resmed Inc	283.90	41.12B	5.15B	1.40B	1.65B	9.51
ALC Alcon Inc	85.75	41.61B	9.93B	1.12B	1.58B	2.25
WST West Pharmaceutical Services Inc	240.98	17.06B	2.90B	467.20M	306.90M	6.37

Solventum Corp Stock (SOLV) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2025-07-15	업그레이드	Morgan Stanley	Equal-Weight → Overweight
2025-07-01	업그레이드	Argus	Hold → Buy
2025-06-06	개시	KeyBanc Capital Markets	Sector Weight
2025-05-19	업그레이드	Piper Sandler	Neutral → Overweight
2024-12-04	개시	Mizuho	Neutral
2024-10-08	개시	Stifel	Buy
2024-10-07	개시	Piper Sandler	Neutral
2024-09-26	개시	Wolfe Research	Peer Perform
2024-09-05	개시	BTIG Research	Neutral
2024-06-24	개시	Argus	Hold
2024-05-30	개시	Goldman	Sell
2024-05-10	개시	BofA Securities	Neutral
2024-04-10	개시	Morgan Stanley	Equal-Weight
2024-04-08	개시	Wells Fargo	Equal Weight
2024-04-02	개시	Edward Jones	Hold

Solventum Corp 주식(SOLV)의 최신 뉴스

Solventum Corp (SOLV) 재무 분석

Solventum Corp (SOLV)

Solventum Corp Stock (SOLV) Company Profile

SOLV을(를) 다른 주식과 비교

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Solventum Corp 주식(SOLV)의 최신 뉴스

Solventum ups financial guidance as tariff risks fade - MSN

Solventum raises annual profit forecast on strength in surgical equipment - MSN

Should Solventum's (SOLV) Earnings Upgrade and Revenue Growth Prompt Portfolio Reassessment by Investors? - simplywall.st

Solventum 2025 Q2 Earnings Net Income Rises 1.1% - AInvest

Stock Analysis | Solventum OutlookNavigating Mixed Signals Amid Weak Technicals - AInvest

Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook - Investing.com Canada

Solventum Exceeds 2Q25 Expectations with $2.16B Revenue, Reduces Tariff Impact - Medical Device and Diagnostic industry

Goldman Sachs Adjusts Solventum Price Target to $73 From $71, Maintains Sell Rating - MarketScreener

Solventum Stock Gains on Q2 Earnings & Revenue Beat, Margins Improve - The Globe and Mail

Solventum Stock Gains On Q2 Earnings & Revenue Beat, Margins Improve - Barchart.com

Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum - MSN

Solventum Boosts Annual Profit Outlook on Surging Medical Device DemandNews and Statistics - IndexBox

Solventum stock price target raised to $94 by Piper Sandler on strong Q2 - Investing.com Nigeria

Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations - Investing.com

Earnings call transcript: Solventum’s Q2 2025 earnings beat expectations By Investing.com - Investing.com UK

Solventum: Q2 Earnings Snapshot - Connecticut Post

Morgan Stanley Upgrades Solventum (SOLV) on Growth Potential - MSN

Solventum Corp SEC 10-Q Report - TradingView

Solventum Q2 FY25 slides reveal improved performance and increased full-year outlook By Investing.com - Investing.com South Africa

Solventum 2025 Q2 Earnings Positive Earnings Growth with Raised Guidance - AInvest

Solventum (SOLV) Fiscal Q2 EPS Jumps 8% - AOL.com

Solventum Corp reports results for the quarter ended June 30Earnings Summary - TradingView

Solventum (SOLV) Reports Earnings Tomorrow: What To Expect - MSN

Solventum (SOLV) Q2 2025 Earnings Call Transcript - AOL.com

Solventum (SOLV) Fiscal Q2 EPS Jumps 8% - The Motley Fool

Solventum (SOLV) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Solventum (SOLV) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance

Solventum shares surge as raised guidance tops expectations By Investing.com - Investing.com South Africa

Solventum shares surge as raised guidance tops expectations - Investing.com

Solventum reports Q2 adjusted EPS $1.69, consensus $1.45 - TipRanks

Solventum raises annual profit forecast on strength in surgical equipment By Reuters - Investing.com

Solventum Corporation Q2 Sales Increase - Nasdaq

Solventum beats The Street in Q2, raises full-year guidance - MassDevice

Solventum’s (NYSE:SOLV) Q2: Beats On Revenue - Yahoo Finance

Earnings Flash (SOLV) Solventum Corporation Reports Q2 Revenue $2.16B, vs. FactSet Est of $2.12B - MarketScreener

Earnings Flash (SOLV) Solventum Corporation Posts Q2 Adjusted EPS $1.69 per Share, vs. FactSet Est of $1.45 - MarketScreener

Solventum Reports Second Quarter 2025 Financial Results - PR Newswire

Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings? - MSN

Ahead of Solventum (SOLV) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics - MSN

Industry Insider: After 3M Separation, Solventum Targets Digital Integration in Ortho - Orthodontic Products

Solventum SOLV Q2 2025 Earnings Preview Upside Potential Driven by Robust EPS Growth - AInvest

With 68% institutional ownership, Solventum Corporation (NYSE:SOLV) is a favorite amongst the big guns - Yahoo Finance

A Note On Solventum Corporation's (NYSE:SOLV) ROE and Debt To Equity - simplywall.st

Solventum Corp. stock rises Monday, outperforms market - MarketWatch

Can Solventum Corporation Escape Recent Bear ChannelWeekly Chart Analysis With Entry Advice Provided - beatles.ru

How volatile is Solventum Corporation stock compared to the marketCapitalize on market trends with expert guidance - Jammu Links News

How many analysts rate Solventum Corporation as a “Buy”Build wealth faster with consistent investment plans - Jammu Links News

How strong is Solventum Corporation company’s balance sheetCapitalize on market trends with expert guidance - Jammu Links News

What is the dividend policy of Solventum Corporation stockSkyrocketing profit margins - Jammu Links News

Solventum Corp (SOLV) 재무 분석

매출

순이익

현금흐름

주당 순 이익

SOLV과 유사한 종목